AKT1 and osteosarcoma: Accordingly, high expression of various RTKs including c-Met, HER-2, VEGFR-3, IR, and PDGFR-β, IGF2R, and EGFR and activation of the downstream PI3K/Akt pathway, has been demonstrated in osteosarcoma cells [149,150].